Literature DB >> 17460726

The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3.

Kevin O Kisich1, Michael D Howell, Mark Boguniewicz, Heather R Heizer, Nori U Watson, Donald Y M Leung.   

Abstract

Normal skin is often exposed to bacteria, including potent pathogens such as E. coli, Staphylococcus aureus, and Streptococcus sp., but these microbes usually do not cause skin inflammation or infection in healthy individuals. Therefore, we hypothesized that there must be a constitutive mechanism for rapid destruction and elimination of small numbers of bacteria which penetrate the stratum corneum from everyday activities. This study found that exposure of keratinocytes cultured from a number of individuals to S. aureus resulted in approximately 2-3 log better killing than by HaCaT cells within 1 hour. Killing required contact between the keratinocytes and the bacteria, but was not dependent on internalization. Contact between the bacteria and the keratinocytes resulted in rapid deposition of several antimicrobial peptides onto the bacteria, but only human beta-defensin (HBD) 3 accumulated at levels sufficient to account for killing when S. aureus were exposed to human skin explants. Blocking peptide binding of HBD3 inhibited killing of the bacteria, indicating an essential role for beta-defensin 3 in the constitutive killing of bacteria by normal keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460726     DOI: 10.1038/sj.jid.5700861

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  47 in total

1.  Staphylococcus aureus: an introduction.

Authors:  Ian A Myles; Sandip K Datta
Journal:  Semin Immunopathol       Date:  2012-01-27       Impact factor: 9.623

2.  Cyclooxygenase-2 enhances antimicrobial peptide expression and killing of Staphylococcus aureus.

Authors:  Jamie J Bernard; Richard L Gallo
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

Review 3.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms.

Authors:  Peter M Elias; Yutaka Hatano; Mary L Williams
Journal:  J Allergy Clin Immunol       Date:  2008-03-07       Impact factor: 10.793

Review 4.  Host defense peptides in wound healing.

Authors:  Lars Steinstraesser; Till Koehler; Frank Jacobsen; Adrien Daigeler; Ole Goertz; Stefan Langer; Marco Kesting; Hans Steinau; Elof Eriksson; Tobias Hirsch
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 5.  Host defense peptides in the oral cavity and the lung: similarities and differences.

Authors:  G Diamond; N Beckloff; L K Ryan
Journal:  J Dent Res       Date:  2008-10       Impact factor: 6.116

6.  Activity, expression and genetic variation of canine β-defensin 103: a multifunctional antimicrobial peptide in the skin of domestic dogs.

Authors:  Brian C Leonard; Stanley L Marks; Catherine A Outerbridge; Verena K Affolter; Anchasa Kananurak; Amy Young; Peter F Moore; Danika L Bannasch; Charles L Bevins
Journal:  J Innate Immun       Date:  2012-01-19       Impact factor: 7.349

7.  Novel Functions and Signaling Specificity for the GraS Sensor Kinase of Staphylococcus aureus in Response to Acidic pH.

Authors:  Robert C Kuiack; Ruud A W Veldhuizen; Martin J McGavin
Journal:  J Bacteriol       Date:  2020-10-22       Impact factor: 3.490

Review 8.  The roles of antimicrobial peptides in innate host defense.

Authors:  Gill Diamond; Nicholas Beckloff; Aaron Weinberg; Kevin O Kisich
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.

Authors:  Emma Guttman-Yassky; Michelle A Lowes; Judilyn Fuentes-Duculan; Lisa C Zaba; Irma Cardinale; Kristine E Nograles; Artemis Khatcherian; Inna Novitskaya; John A Carucci; Reuven Bergman; James G Krueger
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute.

Authors:  Michael J Schurr; Kevin N Foster; John M Centanni; Allen R Comer; April Wicks; Angela L Gibson; Christina L Thomas-Virnig; Sandy J Schlosser; Lee D Faucher; Mary A Lokuta; B Lynn Allen-Hoffmann
Journal:  J Trauma       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.